摘要:
A flexible standing pouch made from a single sheet of packaging material having a fitment with a flat flange for mounting cap or dispensing device sealed onto a folded edge forming the top of the package, seams on each side and a bottom formed by turning the opposing corners of the bottom of the flat package downward, compressing them and turning them inward to form a flat bottom.
摘要:
Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.
摘要:
Disclosed is a novel process and novel intermediates to prepare [R-(R*,R*)]-N-[3-[1-[5,6-dihydro-4-hydroxy-2-oxo-6-(2-phenylethyl)-6-propyl-2H-pyran-3-yl]propyl]phenyl]-5-(trifluoromethyl)-2-pyridinesulfonamide (XIX) ##STR1## which is a protease inhibitor useful in treating humans infected with the HIV virus.
摘要:
1,2,8,8a-Tetrahydrocyclopropa[3]pyrrolo(3,2-e)indol-4(5H)-ones, and related compounds of formulas I and intermediate therefor II ##STR1## wherein R.sub.2, R.sub.2 ', R.sub.3, R.sub.5, R.sub.50 and X are as defined in the specification, e.g., (7bR,8aS)-1,2,8,8a-tetrahydro-7-methyl-2-[[5-(((1H-indol-2-yl)carbonyl)amino)-1H-indol-2-yl]carbonyl]cyclopropa[pyrrolo[3,2-e]indol-4(5H)-one (U-71,184), as purified, and its racemic form (U-68,415), and related compounds, are useful as ultraviolet light absorbers and as antibacterials. The lead compounds are useful as antitumor drug compounds in standard laboratory animal tests.
摘要:
Method and apparatus for forming, filling and sealing bags from a continuous supply of bagging material, the apparatus including a pair of sealing jaws transversely movable toward each other to engage the bagging material to form a transverse seal providing the top closure for a filled bag and the bottom closure for a succeeding bag. The improvement includes stretch assemblies attached to the sealing jaws and engageable with the bagging material at opposite edges thereof to provide opposing forces in directions perpendicular to the movement of the sealing jaws to flatten the bag and remove any wrinkles therefrom prior to sealing of the bags by the sealing jaws.
摘要:
Racemic mixtures and optically active isomers of (.alpha.S-5S)-.alpha.-amino-3-chloro-.alpha.-isoxazoline-5-acetic acid (AT-125). Provides process for preparing AT-125 and its analogs and intermediates used in the process.This case is a continuation of Ser. No. 906,175 filed May 15, 1978, now abandoned.
摘要:
A pair of endless belts of different lengths are intermittently and simultaneously advanced in sequential steps to present first and second indicia behind a viewing window. Each of the indicia on one belt identifies a movable part of a person's body and each of the indicia on the other belt identifies a movement to be performed. The indicia on each belt include a plurality of legends identifying each body part or movement, respectively, but arranged randomly in series on the belts. A selectively operable control serves to vary the time interval between sequential steps.
摘要:
The present invention relates to novel 2-decarboxy-2-hydroxymethyl-9-deoxy-6,9.alpha.-epoxymethano-5,6-didehydro-PGF.sub.1 compounds, which are useful for inducing a variety of prostacyclin-like pharmacological effects. Accordingly, these compounds are useful pharmacological agents for the same purposes for which prostacyclin is employed.
摘要:
Prostaglandin (PG.sub.1) derivatives having (1) a 6-keto feature, together with a 9-deoxy-9-hydroxymethyl feature for example ##STR1## or (2) a 9-deoxy-6,9-epoxymethano feature together with a 5-halo or 6-hydroxy feature, for example ##STR2## or a 5,6-didehydro feature, for example in an enol ether of the formula ##STR3## said derivatives having pharmacological activity. Processes for preparing them and the appropriate intermediates are disclosed.
摘要:
Processes for preparing prostacyclin analogs which are 9-deoxy-6,9-epoxymethano derivatives of prostaglandin F.sub.1 .alpha. -type compounds, illustrated, for example, by a compound of the formula ##STR1## wherein .about. indicates alpha or beta configuration; including the products and intermediates produced therein, said products having pharmacological utility.